ISDA

Deposition Date 2009-01-29

Release Date 2009-03-17

Last Version Date 2023-09-06

Entry Detail

PDB ID:

3G11

Keywords:

TRANSFERASE

Title:

Structure of E. coli FabF(C163Q) in complex with dihydrophenyl platensimycin

Biological Source:

Source Organism:

Escherichia coli (Taxon ID: 83333)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.00 Å

R-Value Free:

0.20

R-Value Work:

0.16

R-Value Observed:

0.16

Space Group:

P 31 2 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:3-oxoacyl-[acyl-carrier-protein] synthase 2
Gene (Uniprot):fabF
Mutations:C163Q
Chain IDs:A
Chain Length:427
Number of Molecules:1
Biological Source:Escherichia coli

UniProt ID:P0AAI5 Pfam ID:PF00109, PF02801 EC:2.3.1.179

Ligand Molecules

P9C

Primary Citation

Synthesis and biological evaluation of platensimycin analogs.

Shen, H.C, Ding, F.X, Singh, S.B, Parthasarathy, G, Soisson, S.M, Ha, S.N, Chen, X, Kodali, S, Wang, J, Dorso, K, Tata, J.R, Hammond, M.L, Maccoss, M, Colletti, S.L.Show

Bioorg.Med.Chem.Lett. 19 1623 1627 (2009)

PMID: 19233644 DOI: 10.1016/j.bmcl.2009.02.006

Abstact

Platensimycin (1) displays antibacterial activity due to its inhibition of the elongation condensing enzyme (FabF), a novel mode of action that could potentially lead to a breakthrough in developing a new generation of antibiotics. The medicinal chemistry efforts were focused on the modification of the enone moiety of platensimycin and several analogs showed significant activity against FabF and possess antibacterial activity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures